V

Veracyte
D

VCYT

39.780
USD
-0.76
(-1.87%)
Post Trading·39.610USD-0.170(-0.43%)
حجم التداول
27,552
الربح لكل سهم
2
العائد الربحي
-
P/E
28
حجم السوق
3,197,943,279
أصول ذات صلة المقالات
المزيد

العنوان: Veracyte

القطاع: الرعاية الصحية
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).